-
The good news is there are many more adolescents who do use condoms today than probably at any other time in history, says Claire Brindis, DrPH, director of the Center for Reproductive Health Research and Policy at the University of California, San Francisco.
-
-
Phase III effectiveness clinical trials have begun for the potential anti-HIV microbicide cellulose sulfate (Ushercell), formerly called C31G, which already has demonstrated safety when used by women. If the trials go well, the product could be ready for approval by the Food and Drug Administration (FDA) by 2010.
-
Two hundred short-term volunteer health care providers are needed to improve the quality of care provided to more than 500,000 HIV patients in developing countries.
-
-
Appropriate use of anticoagulants offers both opportunity and challenge for the primary care clinician. This discussion is directed toward simplifying the pathophysiology and effective use of anticoagulation in the primary care setting.
-
-
The most commonly prescribed statins have a low incidence of rhabdomyolysis, according to the results a new study of more than 250,000 patients.
-
It has been 17 years since the National Institute for Occupational Safety and Health formally recognized psychological disorders as a leading occupational health risk, but getting American businesses to accept the benefits offered by occupational health psychology may take longer than that.
-
Occupational Health Management editorial advisory board member Deborah V. DiBenedetto, past president of the American Association of Occupational Health Nurses and a nationally recognized consultant on occupational health issues, provides more information on the relationship between the Health Insurance Portability and Accountability Act, employee health records, and the occupational health nurse.
